BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gulati N, Chellappan DK, MacLoughlin R, Dua K, Dureja H. Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospects. Life Sci 2021;285:119969. [PMID: 34547339 DOI: 10.1016/j.lfs.2021.119969] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Meng L, Liao X, Wang Y, Chen L, Gao W, Wang M, Dai H, Yan N, Gao Y, Wu X, Wang K, Liu Q. Pharmacologic therapies of ARDS: From natural herb to nanomedicine. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.930593] [Reference Citation Analysis]
2 Zhou Y, Xiao Z, Zhu W. The roles of small extracellular vesicles as prognostic biomarkers and treatment approaches in triple-negative breast cancer. Front Oncol 2022;12:998964. [DOI: 10.3389/fonc.2022.998964] [Reference Citation Analysis]
3 Azhdari MH, Goodarzi N, Doroudian M, MacLoughlin R. Molecular Insight into the Therapeutic Effects of Stem Cell-Derived Exosomes in Respiratory Diseases and the Potential for Pulmonary Delivery. Int J Mol Sci 2022;23:6273. [PMID: 35682948 DOI: 10.3390/ijms23116273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cazzola M, Ora J, Calzetta L, Rogliani P, Matera MG. The future of inhalation therapy in chronic obstructive pulmonary disease. Current Research in Pharmacology and Drug Discovery 2022;3:100092. [DOI: 10.1016/j.crphar.2022.100092] [Reference Citation Analysis]